The herein presented PBPK model adequately describes the pharmacokinetics of moxifloxacin in adults.

In particular, it applies quantitative metabolism via glucuronidation and sulfate conjugation, and elimination via renal and biliary clearance. Thus, the model is fit for purpose to be applied for simulation of intravenous and oral administration of moxifloxacin in adults.

